- Home
- BLRX vs EQS Comparison
BLRX vs EQS Comparison
Compare BLRX & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- EQS
- Stock Information
- Founded
- BLRX 2003
- EQS 1991
- Country
- BLRX Israel
- EQS United States
- Employees
- BLRX N/A
- EQS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- BLRX Health Care
- EQS Finance
- Exchange
- BLRX Nasdaq
- EQS Nasdaq
- Market Cap
- BLRX 17.3M
- EQS 14.9M
- IPO Year
- BLRX 2011
- EQS N/A
- Fundamental
- Price
- BLRX $0.10
- EQS $1.25
- Analyst Decision
- BLRX Strong Buy
- EQS
- Analyst Count
- BLRX 2
- EQS 0
- Target Price
- BLRX $5.50
- EQS N/A
- AVG Volume (30 Days)
- BLRX 18.8M
- EQS 17.8K
- Earning Date
- BLRX 11-25-2024
- EQS 01-01-0001
- Dividend Yield
- BLRX N/A
- EQS N/A
- EPS Growth
- BLRX N/A
- EQS N/A
- EPS
- BLRX N/A
- EQS N/A
- Revenue
- BLRX $21,991,000.00
- EQS $1,137,000.00
- Revenue This Year
- BLRX N/A
- EQS N/A
- Revenue Next Year
- BLRX N/A
- EQS N/A
- P/E Ratio
- BLRX N/A
- EQS N/A
- Revenue Growth
- BLRX N/A
- EQS 1795.00
- 52 Week Low
- BLRX $0.08
- EQS $1.01
- 52 Week High
- BLRX $1.44
- EQS $1.95
- Technical
- Relative Strength Index (RSI)
- BLRX 28.83
- EQS 58.81
- Support Level
- BLRX $0.23
- EQS $1.01
- Resistance Level
- BLRX $0.14
- EQS $1.37
- Average True Range (ATR)
- BLRX 0.03
- EQS 0.12
- MACD
- BLRX -0.00
- EQS 0.02
- Stochastic Oscillator
- BLRX 6.93
- EQS 66.67
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.